CD44 and breast neoplasm: These findings indicate that DOX-loaded HA micelles exhibit optimal CD44-mediated targeting ability and pH-dependent drug release in the acidic tumor microenvironment, which could result in enhanced breast tumor-targeting efficiency and reduced drug-induced side effects.